Device Trial Radar · NCT06460246
Pulse Oximeter Accuracy During Stable Hypoxia Plateaus
Last checked: Nov 20, 2026Latest source record: Aug 23, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
12
Actual
Start
Jun 25, 2024
Primary completion
Jun 27, 2024
Study completion Jul 31, 2024
Sponsor
- Lead sponsor
- Acurable Ltd.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Jun 14, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Other
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 50 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This project aims to test the accuracy of pulse oximeters in the range of arterial HbO2 saturations from 100% down to 70%.
Conditions
- Healthy
Interventions
Pulse OximeterDevice
The subjects will have a 22-gauge catheter inserted in the radial artery to measure the oxygen saturation of arterial blood and also wear pulse oximeters.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Performance of the pulse oximeters against corresponding arterial blood oxygen saturation.Time frame: 1-4 hours
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Vital Signs Research Group, L.L.C.
San Francisco, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.